LI Tuojian, ZHANG Chao, CHEN Zongtao, LI Xinliang. Methylation status of Septin 9 in peripheral blood and its relationship with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 5-8, 13. DOI: 10.7619/jcmp.20222618
Citation: LI Tuojian, ZHANG Chao, CHEN Zongtao, LI Xinliang. Methylation status of Septin 9 in peripheral blood and its relationship with colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 5-8, 13. DOI: 10.7619/jcmp.20222618

Methylation status of Septin 9 in peripheral blood and its relationship with colorectal cancer

More Information
  • Received Date: August 22, 2022
  • Available Online: December 01, 2022
  • Objective 

    To detect the methylation status of Septin 9 in the peripheral blood of patients with colorectal cancer (CRC) and analyze the relationship between the methylation of Septin 9 and CRC.

    Methods 

    A total of 120 patients with CRC were selected as research objects, and the relationship between the methylation status of Septin 9 in the peripheral blood and the medical materials was analyzed; the serum exosomes isolated from patients with CRC and healthy people were used to treat the CRC cells, and the proliferation and apoptosis of CRC cells were detected.

    Results 

    A total of 1 586 people with health examinations were screened for Septin 9, and 56 of whom were positive for methylation of Septin 9, with a positive rate of 3.5%. Among patients with Septin 9 positive, there were 20 cases (35.7%) with abnormal gastrointestinal status (gastrointestinal inflammation or polyps), while only 5.4% (83/1 530) of patients with Septin 9 negative had abnormal gastrointestinal status, which indicated that the methylation status of Septin 9 in the peripheral blood was closely related to the gastrointestinal status. Among 120 CRC patients, the positive rate of methylation of Septin 9 was 78.4% (73/93); in the comparison of different differentiation degrees, the positive rates of Septin 9 methylation in patients with highly differentiated, moderately differentiated and poorly differentiated CRC were 52.6% (10/19), 79.7% (59/74) and 88.9% (24/27) respectively, and the positive rate of Septin 9 methylation in peripheral blood of patients with poorly differentiated CRC was significantly higher than that of patients with highly differentiated CRC (P=0.006). The sensitivity and specificity of Septin 9 methylation in the peripheral blood were 72.3% and 92.5% respectively. Western blot results showed that the expression of Septin 9 in the exosomes of CRC patients was significantly lower than that in the normal people, while the methylation level of Septin 9 in the exosomes was significantly higher than that in the healthy people (P=0.009, 0.003). The results of this study showed that serum exosomes of CRC patients could significantly promote cell proliferation and inhibit cell apoptosis (P < 0.05 or P < 0.01).

    Conclusion 

    Septin 9 can be used as a marker for early screening of CRC, and the mechanism of Septin 9 may be the proliferation and apoptosis resistance of CRC induced by serum exosomes in patients with CRC.

  • [1]
    ZENG H M, ZHENG R S, GUO Y M, et al. Cancer survival in China, 2003-2005: a population-based study[J]. Int J Cancer, 2015, 136(8): 1921-1930. doi: 10.1002/ijc.29227
    [2]
    KANG Q, JIN P, YANG L, et al. Significance of Septin 9 gene methylation detection of plasma circulation DNA in colorectal cancer screening[J]. Zhonghua Yi Xue Za Zhi, 2014, 94(48): 3839-3841. .
    [3]
    SUN G P, MENG J, DUAN H, et al. Diagnostic ssessment of Septin 9 DNA methylation for colorectal cancer using blood detection: a meta-analysis[J]. Pathol Oncol Res, 2019, 25(4): 1525-1534. doi: 10.1007/s12253-018-0559-5
    [4]
    LIU T, ZHANG X, DU L T, et al. Exosome transmitted miR-l 28-3p increase chemosensitivity of oxaliplatin-resistant coloretal cancer[J]. Mol Cancer, 2019, 18(1): 43. doi: 10.1186/s12943-019-0981-7
    [5]
    谭琪, 宗明, 處珊珊, 等. 联合检测外周血游离Septin 9、SDC2、BCATI基因甲基化在结直肠癌诊断中的意义[J]. 中华检验医学杂志, 2021, 44(3): 204-211. https://www.cnki.com.cn/Article/CJFDTOTAL-ZMXZ201605028.htm
    [6]
    YANQING H, CHENG D, LING X. Serum CA72-4 as a bionarker in the diagnosis of colorectal cancer: a meta-analysis[J]. Open Med: Wars, 2018, 13: 164-171. doi: 10.1515/med-2018-0026
    [7]
    宋慧琴, 张君娜. Septin 9基因、缺氧诱导因子1与结直肠癌发生发展的相关性[J]. 广州医科大学学报, 2021, 49(1): 14-17. doi: 10.3969/j.issn.2095-9664.2021.01.04
    [8]
    YANG J K, YANG J P, TONG J, et al. Exosomal miR-221 targets DNM3 to induce tumor progression and temozolomide re sistance in glioma[J]. J Neurooncol, 2017, 131(2): 255-265. doi: 10.1007/s11060-016-2308-5
    [9]
    陈培, 邓钦木, 李丹丹. 血浆Septin 9甲基化检测在结直肠癌中的诊断价值[J]. 现代检验医学杂志, 2020, 35(4): 10-13. doi: 10.3969/j.issn.1671-7414.2020.04.003
    [10]
    宫媛, 王卫华, 杜海涛, 等. 外周血Septin 9基因甲基化检测在结直肠癌诊断中的研究进展[J]. 临床输血与检验, 2021, 23(2): 263-268. doi: 10.3969/j.issn.1671-2587.2021.02.028
    [11]
    张春燕, 于正麟, 王蓓丽, 等. 血浆Septin 9基因甲基化检测性能评价及对结直肠癌患者的筛查价值[J]. 临床检验杂志, 2019, 37(2): 152-155. https://www.cnki.com.cn/Article/CJFDTOTAL-LCJY201902018.htm
    [12]
    YAN S S, HAN B, GAO S Y, et al. Exsome-encapsulated micro RNAs as circulating biomarkers for colorectal cancer[J] Oncotarget, 2017, 8(36): 60149-60158. . doi: 10.18632/oncotarget.18557
    [13]
    陈越亚, 陈卫昌. 外周血SEPT9基因甲基化检测在结直肠癌中的研究进展[J]. 中国血液流变学杂志, 2021, 31(2): 265-270. doi: 10.3969/j.issn.1009-881X.2021.02.031
    [14]
    穆剑强, 高海锋. 外周血Septin9基因甲基化和血清CA199联合检测在结直肠癌筛查中的诊断价值[J]. 检验医学与临床, 2022, 19(4): 526-529. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202204023.htm
    [15]
    RICHARDS K E, ZELENIAK A E, FISHEL M L, et al. Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells[J]. Oncogene, 2017, 36(13): 1770-1778.
    [16]
    赵媛, 陈四明, 蒋益兰, 等. Septin-9基因甲基化检测对结直肠癌诊断价值的meta分析[J]. 中国医师杂志, 2020, 22(6): 852-856. doi: 10.3760/cma.j.cn431274-20200222-00172
  • Related Articles

    [1]XU Yan, ZHU Chunyun. Monitoring and protection of peripheral blood cell count for nursing staffs in ward after iodine-125 implantation[J]. Journal of Clinical Medicine in Practice, 2023, 27(13): 123-126. DOI: 10.7619/jcmp.20231229
    [2]ZHOU Xiaohua, YIN Guoyong, YU Tingting, WANG Chengyue, SHI Lei, WEI Jincui. Study on the radiation of C-arm X-ray machine to the non-surgical sites of patients undergoing orthopedic surgery[J]. Journal of Clinical Medicine in Practice, 2022, 26(24): 121-124, 148. DOI: 10.7619/jcmp.20222952
    [3]MIU Yihong, DING Xiaoping, WANG Yanhong. Application of comfort care in protective restraint of female patients with mental disorders[J]. Journal of Clinical Medicine in Practice, 2019, 23(16): 111-113. DOI: 10.7619/jcmp.201916030
    [4]REN Xiaomin, CHEN Rong, XU Yinghua. Effect of simple bath protective sleeve in patients with PICC[J]. Journal of Clinical Medicine in Practice, 2018, (8): 73-75. DOI: 10.7619/jcmp.201808022
    [5]CHEN Hao. Effect of comprehensive protective nursing measures in prevention of lower extremity deep venous thrombosis in perioperation[J]. Journal of Clinical Medicine in Practice, 2017, (8): 156-158. DOI: 10.7619/jcmp.201708046
    [6]ZHOU Zhengqing, SHEN Hua, CHEN Yijing. Electroacupuncture in neiguan and dexmedetomidine for hyperglycemia patients with coronary heart disease in protection of myocardial injury during perioperative period[J]. Journal of Clinical Medicine in Practice, 2016, (24): 55-59. DOI: 10.7619/jcmp.201624016
    [7]ZHANG Guoqiang. Effects of Aidi injection and liver protection decoction combined TACE for moderate or advanced primary liver cancer[J]. Journal of Clinical Medicine in Practice, 2015, (Z1): 75-77.
    [8]WEN Yuqin, HE Li, ZHANG Ming. The exploration of limb skin protection method by noninvasive blood pressure measurement in perioperative period[J]. Journal of Clinical Medicine in Practice, 2014, (10): 99-100,103. DOI: 10.7619/jcmp.201410035
    [9]ZHANG Xiu, JIANG Tianjun, WU Dan, LIU Liying, YUAN Hong, TAN Wenhui, Chen Qian, ZHANG Yumin, MA Yafei. Management of occupational protection for AIDS nursing personnel[J]. Journal of Clinical Medicine in Practice, 2012, (20): 98-100.
    [10]LI Xian-hong. Self-protection of nurses working at the liver transplantation center[J]. Journal of Clinical Medicine in Practice, 2005, (4): 6-7. DOI: 10.3969/j.issn.1672-2353.2005.04.004
  • Cited by

    Periodical cited type(4)

    1. 周炜,蒋俊杰,夏一淼,王利媛,王法财. 替雷利珠单抗药物利用评价标准的建立与应用. 实用药物与临床. 2024(01): 40-45 .
    2. 郭小琦,张璞,李小军,余明,王博. 口服醋酸泼尼松联合局部注射曲安奈德对食管早癌ESD术后食管狭窄及肺部感染的预防疗效分析. 中华肺部疾病杂志(电子版). 2024(02): 288-291 .
    3. 谢杏梅,高悦. 替雷利珠单抗治疗晚期非小细胞肺癌致免疫相关性胰腺炎1例. 中南药学. 2024(08): 2255-2257 .
    4. 赵军华,周志杰,李景萍. 肾病综合征患者应用免疫抑制剂联合激素治疗后并发重症肺炎的相关因素分析. 中国实用医刊. 2024(22): 56-58 .

    Other cited types(0)

Catalog

    Article views (177) PDF downloads (12) Cited by(4)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return